Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Drug companies call for antibiotic funding
Pills in bottle
Antibiotic resistance has increased so much in recent years that it is now considered to be a serious risk to public health.
Government urged to take urgent action

Pharmaceutical companies and industry bodies are warning of a "terrible human cost" unless new ways to fund antibiotics can be found.

In an open letter published in the Financial Times, the organisations urge the government to take urgent action. They also highlight warnings that around 10 million people a year could be killed by drug-resistant bacteria by 2050.

They write that without new antibiotics "everything from routine surgical procedures, to cancer chemotherapy, organ transplantation and even childbirth will become increasingly dangerous."

They add that if we fail to act now, "antimicrobial resistance is also expected to cost the world economy $100tn a year by 2050."

Antibiotic resistance has increased so much in recent years that it is now considered to be a serious risk to public health.

In 2014,the lack of existing antibiotics, together with the lack of new antibiotic treatments led the World Health Organisation to describe the situation as a "post-antibiotic era", where people can die from simple infections that have been treatable for decades.

The letter was signed by professor Colin Garner, chief executive of Antibiotic Research UK; prof Jayne Lawrence, chief scientist at the Royal Pharmaceutical Society; John Rex, a senior AstraZeneca executive; prof Luigi Martini, of King's College London; and Jeremy Lefroy MP.

The letter was also signed by Bioindustry Association chief executive Steve Bates, who told BBC News that companies' investment "needed to be rewarded," but without encouraging the overuse of antibiotics.

He suggested that the government set up a insurance-style scheme in which it paid a fixed fee for antibiotics, so that manufacturers didn't just focus on research into drugs that increased sales. 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.